Catlow J[au] - Search Results

Year	Number of Results
1988	1
1992	1
1995	2
1996	1
1997	1
2005	1
2007	2
2008	1
2010	2
2011	2
2012	1
2013	3
2014	2
2015	4
2016	6
2017	5
2018	1
2019	2
2020	2
2021	5
2022	2

1

Expansion of Knowledge on OCT1 Variant Activity In Vitro and In Vivo Using Oct1/2^-/- Mice.

Morse BL, Chen LH, Catlow JT, Fallon JK, Smith PC, Hillgren KM. Morse BL, et al. Among authors: catlow jt. Front Pharmacol. 2021 Feb 15;12:631793. doi: 10.3389/fphar.2021.631793. eCollection 2021. Front Pharmacol. 2021. PMID: 33658943 Free PMC article.

2

Decision making in the management of adults with malignant colorectal polyps: An exploration of the experiences of patients and clinicians.

Westwood C, Lee T, McSherry R, Bettany-Saltikov J, Catlow J. Westwood C, et al. Among authors: catlow j. Colorectal Dis. 2021 Aug;23(8):2052-2061. doi: 10.1111/codi.15743. Epub 2021 Jun 16. Colorectal Dis. 2021. PMID: 34008306

3

JAG/BSG national survey of UK endoscopy services: impact of the COVID-19 pandemic and early restoration of endoscopy services.

Catlow J, Beaton D, Beintaris I, Shaw T, Broughton R, Healey C, Penman I, Coleman M, Rutter M. Catlow J, et al. Frontline Gastroenterol. 2020 Aug 21;12(4):272-278. doi: 10.1136/flgastro-2020-101582. eCollection 2021. Frontline Gastroenterol. 2020. PMID: 34249311 Free PMC article.

4

Power of big data to improve patient care in gastroenterology.

Catlow J, Bray B, Morris E, Rutter M. Catlow J, et al. Frontline Gastroenterol. 2021 May 28;13(3):237-244. doi: 10.1136/flgastro-2019-101239. eCollection 2022. Frontline Gastroenterol. 2021. PMID: 35493622 Free PMC article.

5

The National Endoscopy Database (NED) Automated Performance Reports to Improve Quality Outcomes Trial (APRIQOT) randomized controlled trial design.

Catlow J, Sharp L, Kasim A, Lu L, Brookes M, Lee T, McCarthy S, Gray J, Sniehotta F, Deane J, Rutter M. Catlow J, et al. Endosc Int Open. 2020 Nov;8(11):E1545-E1552. doi: 10.1055/a-1261-3151. Epub 2020 Oct 21. Endosc Int Open. 2020. PMID: 33140009 Free PMC article.

6

Modulation of TARP γ8-Containing AMPA Receptors as a Novel Therapeutic Approach for Chronic Pain.

Knopp KL, Simmons RMA, Guo W, Adams BL, Gardinier KM, Gernert DL, Ornstein PL, Porter W, Reel J, Ding C, Wang H, Qian Y, Burris KD, Need A, Barth V, Swanson S, Catlow J, Witkin JM, Zwart R, Sher E, Choong KC, Wall TM, Schober D, Felder CC, Kato AS, Bredt DS, Nisenbaum ES. Knopp KL, et al. Among authors: catlow j. J Pharmacol Exp Ther. 2019 Jun;369(3):345-363. doi: 10.1124/jpet.118.250126. Epub 2019 Mar 25. J Pharmacol Exp Ther. 2019. PMID: 30910921

7

Further Evaluation of Mechanisms Associated with the Antidepressantlike Signature of Scopolamine in Mice.

Martin AE, Schober DA, Nikolayev A, Tolstikov VV, Anderson WH, Higgs RE, Kuo MS, Laksmanan A, Catlow JT, Li X, Felder CC, Witkin JM. Martin AE, et al. Among authors: catlow jt. CNS Neurol Disord Drug Targets. 2017;16(4):492-500. doi: 10.2174/1871527316666170309142646. CNS Neurol Disord Drug Targets. 2017. PMID: 28294051

8

Further evaluation of the neuropharmacological determinants of the antidepressant-like effects of curcumin.

Witkin JM, Leucke S, Thompson LK, Lynch RA, Ding C, Heinz B, Catlow JT, Gleason SD, Li X. Witkin JM, et al. Among authors: catlow jt. CNS Neurol Disord Drug Targets. 2013 Jun;12(4):498-505. doi: 10.2174/1871527311312040008. CNS Neurol Disord Drug Targets. 2013. PMID: 23574162

9

Forebrain-selective AMPA-receptor antagonism guided by TARP γ-8 as an antiepileptic mechanism.

Kato AS, Burris KD, Gardinier KM, Gernert DL, Porter WJ, Reel J, Ding C, Tu Y, Schober DA, Lee MR, Heinz BA, Fitch TE, Gleason SD, Catlow JT, Yu H, Fitzjohn SM, Pasqui F, Wang H, Qian Y, Sher E, Zwart R, Wafford KA, Rasmussen K, Ornstein PL, Isaac JT, Nisenbaum ES, Bredt DS, Witkin JM. Kato AS, et al. Among authors: catlow jt. Nat Med. 2016 Dec;22(12):1496-1501. doi: 10.1038/nm.4221. Epub 2016 Nov 7. Nat Med. 2016. PMID: 27820603

10

Targeted Blockade of TARP-γ8-Associated AMPA Receptors: Anticonvulsant Activity with the Selective Antagonist LY3130481 (CERC-611).

Witkin JM, Schober DA, Gleason SD, Catlow JT, Porter WJ, Reel J, Jin X, Hobbs J, Gehlert D, Gernert DL, Gardinier KM, Kato AS, Ping X, Smith JL. Witkin JM, et al. Among authors: catlow jt. CNS Neurol Disord Drug Targets. 2017;16(10):1099-1110. doi: 10.2174/1871527316666171101132047. CNS Neurol Disord Drug Targets. 2017. PMID: 29090671

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results